VectorB2B will attend the Global Clinical Trials Connect 2023 on 10-11 May in London

The Global Clinical Trials Connect 2023 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research, clinical trials planning and management.

The Pharma and Bio-Tech companies are consistently evolving and new clinical studies, technologies and advancements in care and treatments have augmented the efficiency and at the same time the complexity of clinical trials has increased, with tests being carried out in a highly structured and closely coordinated manner. It is high time that we look into innovative strategies, new technologies, effective and quality collaborations to address these issues, which can cater to the needs of the patient and the industry.

This conference intends to focus on the global health and clinical trials around the world. Bioethics, regulations, patient recruitment, site selection, real-world data, data integration & Strategy, outsourcing, vendor management, quality (QbD) in Trial Conduct, risk-based monitoring, clinical auditing & financial planning and other significant topics that play a key role in clinical trials will be addressed along with innovative sessions on new technologies, effective and quality collaborations.

This program will certainly educate health care scientists on trial design, operations, organizing trials, research computing, regulatory aspects, report on clinical trials and gain a better knowledge of the implications of clinical trials in prevention, diagnosis, clinical trial-related ethics and disease treatments.

More News

VectorB2B will exhibit at BIOSPAIN 2023 on 26-28 Sept in Barcelona

BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings and companies participating. 34% of delegates came from outside of Spain. This year, BIOSPAIN goes back to Barcelona, the main biotech cluster in Spain and one of […]

VectorB2B will exhibit at the European Drug Discovery Innovation Congress on 12-13 Sept in Barcelona

This event has a reputation for providing outstanding networking experiences with industry experts, thought leaders and fellow attendees to explore the latest trends, innovations, and challenges in the drug discovery landscape. Meet us at VectorB2B booth Link for the conference: https://worldbigroup.com/20th-Drug-Discovery/

VectorB2B is part of the Bio-Hub consortium aiming for the development of new biopharmaceuticals in Portugal targeting international markets

VectorB2B is one of the co-promoters of the Bio-Hub Agenda – a National R&D Platform for…

© 2024 digital connection | All rights reserved | Privacy policy| Data Privacy Contact Form